肝细胞性肝癌

  • 网络HCC;hepatocellular carcinoma,HCC;hepatocellular carcinoma HCC
肝细胞性肝癌肝细胞性肝癌
  1. 方法:从人肝细胞性肝癌组织中提取总RNA,RT-PCR扩增出MAGE1基因。

    Methods : The mRNA of MAGE 1 gene was isolated from HCC tissue , and the cDNA was amplified by RT PCR .

  2. 方法40例肝细胞性肝癌(HCC)分两组:一组26例,来自广西扶绥地区已知HCC、黄曲霉毒素(AFB1)和乙型肝炎病毒(HBV)高危区;

    Methods 40 cases of archival HCC samples were divided into two groups . One includes 26 cases from Fusui-an area notorious for high risk in HCC , AFB1 and HBV ;

  3. 胆管细胞性肝癌与肝细胞性肝癌侵犯胆管的CT及MRI影像学特征分析

    CT and MR Imaging Differences Between Intrahepatic Cholangiocarcinoma and Hepatocellular Carcinoma with Invasions to Biliary Tracts

  4. 抑癌基因PTEN在人原发性肝细胞性肝癌中的表达、突变及其生物学意义

    Involvement of PTEN Expression and Mutation in Human primary Hepatocellular Carcinoma

  5. E钙粘蛋白、syndecan-1蛋白在肝细胞性肝癌中的表达与肝癌侵袭的关系

    Relationship between epithelial cadherin and syndecan-1 expressions and invasive characters in hepatocellular carcinoma

  6. HBV可以引起肝脏的急、慢性感染,并可能发展为肝硬化、肝细胞性肝癌。

    Viral infection may progress to acute or chronic hepatitis , and may eventually cause cirrhosis and hepatocellular carcinoma ( HCC ) .

  7. 目的探讨肝细胞性肝癌(HCC)组织中转化生长因子β2(TGFβ2)的表达及其临床病理学意义。

    Objective To detect the expression of TGF β 2 and its clinicopathologic significance in hepatocellular carcinoma ( HCC ) .

  8. 用ABC免疫组织化学方法,对南宁地区居民中13例肝细胞性肝癌(HCC)的活检组织进行研究。

    Immunohistochemistry ABC method was used to study 13 biopsy casses of hepatocellular carcinoma ( HCC ) in Nanning prefectural district .

  9. 目的研究人肝细胞性肝癌组织、癌旁组织和正常肝组织中雄激素受体(AR)和雌激素受体(ER)的表达水平及分布规律。

    Objective To study the expression and distribution of androgen receptor ( AR ) and estrogen receptor ( ER ) in human hepatocellular carcinoma .

  10. 原发性肝癌是世界排名第五恶性肿瘤,这其中90%以上是肝细胞性肝癌(Hepatocellularcarcinoma,HCC)。

    Primary liver cancer is the fifth most common cause of cancer , and hepatocellular carcinoma ( HCC ) accounts for more than 90 % of them .

  11. 原发性肝细胞性肝癌(HCC)是最常见的原发恶性肿瘤之一,死亡率极高,位居肿瘤发病率第五,占肿瘤死亡率的第四位。

    Hepatocellular carcinoma ( HCC ) is the fifth most prevalent cancer , and the fourth common cause of cancer related mortality worldwide .

  12. 肝细胞性肝癌组织中HBX蛋白与骨桥蛋白的表达

    Expression of HBX and OPN in hepatocellular carcinoma and the clinical significances

  13. 目的分析采用低机械指数连续实时成像技术时肝细胞性肝癌(HCC)超声造影的增强模式。

    Objective To evaluate the enhancement pattern of hepatocellular carcinoma ( HCC ) at contrast-enhanced ultrasound using low mechanical index and continuous real-time imaging method .

  14. 目的:研究肝细胞性肝癌(HCC)发生过程中不同阶段细胞周期调控相关因子表达及其相互关系,以探讨HCC发生的分子生物学机制。

    Objective : To study the expressions and correlations of cell cycle regulatory components in the hepatocellular carcinogenesis and to identify the molecular mechanism of hepatocarcinogenesis .

  15. 血小板反应蛋白-1及受体CD36在肝细胞性肝癌中的表达及意义

    Significance of expression of thrombospondin-1 and receptor-CD36 in hepatocellular carcinoma

  16. 验证一种新的肝细胞性肝癌预后分期系统:JIS评分系统与CLIP评分系统比较

    Validation of a new prognostic staging system for hepatocellular carcinoma : The JIS score compared with the CLIP score

  17. 目的评价微血管造影成像(microflowimaging,MFI)对肝细胞性肝癌(HCC)微血管构筑的显示,探讨HCC血管构筑与病理分化程度的关系。

    Objective To evaluate the value of contrast-enhanced ultrasound micro flow imaging ( MFI ) in depicting the micro vascular architecture of hepatocellular carcinoma ( HCC ) and the correlation with pathological differentiation .

  18. 原发性肝细胞性肝癌(Hepatocellularcarcinoma,HCC)是严重危害人类生命健康的恶性肿瘤之一,全球每年有一半以上的新发肝癌发生在中国。

    Primary hepatocellular carcinoma ( HCC ) is one of malignant tumors which cause serious harm to human life and health . Half of new liver cancer cases were estimated to occur in China .

  19. 目的探讨MAGE-1基因编码的肿瘤相关抗原作为肝细胞性肝癌(HCC)主动免疫治疗攻击靶点的可能性。

    Objective To explore the possibility of tumor associated antigen encoded by MAGE-1gene used as a tarest for immunotherapy in HCC patients .

  20. Syndecan-1在肝细胞性肝癌中表达的研究

    Study of syndecan - 1 expression in hepatocellular carcinoma

  21. MAGE-1基因在肝细胞性肝癌中的表达

    Expression of MAGE-1 gene in hepatocellular carcinoma

  22. 肝细胞性肝癌AFP-mRNA检测外周血癌细胞的价值

    Peripheral circulating cancer cells with AFP-mRNA detection in hepatocellular carcinoma

  23. 目的探讨超声造影(CEUS)在肝细胞性肝癌(HCC)与肝硬化再生结节诊断和鉴别诊断中的应用价值。

    Objective To assess the value of contrast-enhanced ultrasound ( CEUS ) in the diagnosis of hepatocellular cancer ( HCC ) and the nodus of liver cirrhosis .

  24. Glypican-3在原发性肝细胞性肝癌中的表达及其临床意义

    The expression and clinic significance of Glypican-3 protein in primary human hepatocellular carcinoma

  25. 用多聚酶链反应(PCR)技术检测了16例肝细胞性肝癌(HCC)患者癌灶和癌旁双份组织石蜡包埋标本中的乙型肝炎病毒脱氧核糖核酸(HBV-DNA)。

    PCR technique was used to detect HBV DNA in paraffin-embedded liver tissues to study the prevalence of HBV-DNA in tumorous and nearby nontumorous liver tissues from 16 hepatocellular carcinoma ( HCC ) patients .

  26. 结论:提示P16蛋白的表达与肝细胞性肝癌的分化程度有关,与肿瘤大小有关。

    Conclusion : The expression of P16 protein is related to the degree of the differentiation but not related to the size of the humors .

  27. 目的研究热休克蛋白90α(HSP90α)在人肝细胞性肝癌(HCC)组织中的表达,并探讨其与肿瘤生物学行为及预后的关系。

    Objective To investigate the expression of heat shock proteins 90 α( HSP90 α) in human hepatocellular carcinoma and the relationship between its expression and biologic behavior of tumor and prognosis .

  28. 结果常规超声和CEUS的诊断正确率对肝细胞性肝癌分别为86.8%、88.6%,对转移性肝癌分别为97.6%、99.2%。

    Results The true diagnosis in conventional ultrasound and CEUS were 86.8 % and 88.6 % for hepatocellular carcinoma , 97.6 % and 99.2 % for metastatic liver cancer .

  29. 检测MIF在慢性乙型肝炎、重型肝炎、肝炎肝硬化和肝细胞性肝癌中的表达差异。

    [ Objective ] : 1 . To examine the difference of MIF expression in chronic hepatitis B , severe hepatitis , hepatitis-induced hepatocirrhosis and hepatocellular carcinoma ( HCC ) .

  30. 方法作者对105例肝细胞性肝癌行肝叶切除术的病例进行了术中动脉血酮体比率(AKBR)连续监测。

    Methods Arterial blood ketone body ratio ( AKBR ) was measured during hepatectomy operation in 109 cases with hepatocellular carcinoma .